These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11955793)

  • 1. The impact of testosterone imbalance on depression and women's health.
    Rohr UD
    Maturitas; 2002 Apr; 41 Suppl 1():S25-46. PubMed ID: 11955793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and antiandrogens.
    Schneider HP
    Ann N Y Acad Sci; 2003 Nov; 997():292-306. PubMed ID: 14644837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of circulating androgens in mid-life women: the study of women's health across the nation.
    Santoro N; Torrens J; Crawford S; Allsworth JE; Finkelstein JS; Gold EB; Korenman S; Lasley WL; Luborsky JL; McConnell D; Sowers MF; Weiss G
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4836-45. PubMed ID: 15840738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of sex hormone-binding globulin blood concentrations in premenopausal and postmenopausal women with different estrogen status. Virgilio-Menopause-Health Group.
    Pasquali R; Vicennati V; Bertazzo D; Casimirri F; Pascal G; Tortelli O; Labate AM
    Metabolism; 1997 Jan; 46(1):5-9. PubMed ID: 9005961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B; Apaydin E; Semerci B; Altay B; Cikili N; Nazli O
    Int J Impot Res; 2005; 17(2):148-53. PubMed ID: 15592425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in androgens during treatment with four low-dose contraceptives.
    Coenen CM; Thomas CM; Borm GF; Hollanders JM; Rolland R
    Contraception; 1996 Mar; 53(3):171-6. PubMed ID: 8689882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen replacement for women.
    Basson R
    Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen treatment in women.
    Davis SR
    Med J Aust; 1999 Jun; 170(11):545-9. PubMed ID: 10397047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the Endocrine Society's Clinical Practice Guidelines on Androgen Therapy in Women misguided? A commentary.
    Traish A; Guay AT; Spark RF;
    J Sex Med; 2007 Sep; 4(5):1223-34; discussion 1234-5. PubMed ID: 17727347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women.
    Basaria S; Nguyen T; Rosenson RS; Dobs AS
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):209-14. PubMed ID: 12153599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
    Rannevik G; Jeppsson S; Johnell O; Bjerre B; Laurell-Borulf Y; Svanberg L
    Maturitas; 1995 Feb; 21(2):103-13. PubMed ID: 7752947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens.
    Cappelletti M; Wallen K
    Horm Behav; 2016 Feb; 78():178-93. PubMed ID: 26589379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement therapy in naturally and surgically menopausal women.
    Panzer C; Guay A
    J Sex Med; 2009 Jan; 6(1):8-18; quiz 19-20. PubMed ID: 19170830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen replacement in menopause.
    Burd ID; Bachmann GA
    Curr Womens Health Rep; 2001 Dec; 1(3):202-5. PubMed ID: 12112971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.